Delayed onset autoimmune cholangitis in a patient treated with pembrolizumab

被引：0

作者：

Newington, Joshua ^{[1
]}

Patterson, Daniel ^{[2
]}

Sanchez, Pilar ^{[3
]}

机构：

[1] Univ Cambridge, Addenbrookes Hosp, Hills Rd, Cambridge CB2 0SP, England

[2] West Suffolk Hosp, Dept Oncol, Bury St Edmunds IP33 2QZ, England

[3] West Suffolk Hosp, Dept Radiol, Bury St Edmunds IP33 2QZ, England

来源：

BJR CASE REPORTS | 2024年 / 10卷 / 06期

关键词：

pembrolizumab; autoimmune cholangitis; delayed onset;

D O I：

10.1093/bjrcr/uaae040

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

This case study describes a female patient in her late 70s who developed autoimmune cholangitis a year after finishing 35 cycles of pembrolizumab for the treatment of her non-small cell lung cancer. The diagnosis was initially missed and delayed; the patient's agoraphobia and the COVID-19 pandemic were noted as contributing factors.

引用

页数：4

共 50 条

[31] Pembrolizumab induced autoimmune insulin resistance
Li, Kai
Smollin, Craig
CLINICAL TOXICOLOGY, 2017, 55 (07) : 825 - 825
[32] Prolonged efficacy of pembrolizumab in a patient presenting a multi-treated metastatic hepatocholangiocarcinoma
Saint, Angelique
Benchetrit, Maxime
Novellas, Sebastien
Ouzan, Denis
Falk, Alexander Tuan
Leysalle, Axel
Barriere, Jerome
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2020, 13
[33] Pulmonary pleomorphic carcinoma in an elderly patient treated with pembrolizumab shows a marked response
Yamasaki, Masahiro
Matsumoto, Yu
Nakamoto, Kanako
Hattori, Noboru
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 17 (06) : 1580 - 1582
[34] Multiple autoimmune side effects of immune checkpoint inhibitors in a patient with metastatic melanoma receiving pembrolizumab
Kethireddy, Nikhila
Thomas, Steffi
Bindal, Poorva
Shukla, Prateek
Hegde, Upendra
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (01) : 207 - 211
[35] Inflammatory Thoracic Aortic Aneurysm in a Patient with Advanced Lung Adenocarcinoma Treated with Pembrolizumab
Ninomiya, Ryusuke
Kinehara, Yuhei
Tobita, Satoshi
Konaka, Hachiro
Jokoji, Ryu
Shintani, Takashi
Tachibana, Isao
INTERNAL MEDICINE, 2022, 61 (15) : 2339 - 2341
[36] Anti-PD-1 pembrolizumab induced autoimmune diabetes in Chinese patient A case report
Li, Sicheng
Zhang, Yi
Sun, Zhichun
Hu, Ji
Fang, Chen
MEDICINE, 2018, 97 (45)
[37] Case Report: Treatment of Autoimmune Cholangitis
Leonhard Mohr
Tobias Heintges
Frank Hensel
Claus Niederau
Dieter Haussinger
Digestive Diseases and Sciences, 1998, 43 : 2160 - 2163
[38] The entity "autoimmune cholangitis": hanging by a thread?
Journal of Gastroenterology, 1999, 34 (5) : 657 - 658
[39] Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
Sarcognato, Samantha
Sacchi, Diana
Grillo, Federica
Cazzagon, Nora
Fabris, Luca
Cadamuro, Massimiliano
Cataldo, Ivana
Covelli, Claudia
Mangia, Alessandra
Guido, Maria
PATHOLOGICA, 2021, 113 (03) : 170 - 184
[40] Case report of polymyalgia rheumatica in a male patient with three different neoplasms treated with pembrolizumab
Perrotta, F. M.
Scriffignano, S.
Fatica, M.
Specchia, M.
Lubrano, E.
REUMATISMO, 2020, 72 (03) : 178 - 181

← 1 2 3 4 5 →